SCHEMBL9007825

SCHEMBL9007825

O=c1[nH]c2ccc(Cl)cc2c(=O)cc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.65
CYP1A2 P05177 1/20 0.60
GAA P10253 1/20 0.60
HPGD P15428 1/20 0.60
GRIN2D O15399 2/20 0.56
GRIN3B O60391 2/20 0.56
GRIN1 Q05586 2/20 0.56
GRIN2A Q12879 2/20 0.56
GRIN2B Q13224 2/20 0.56
GRIN2C Q14957 2/20 0.56
GRIN3A Q8TCU5 2/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 1/20 0.54
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
PARP1 P09874 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7350621 0.86 DAO (0.65) DAOCYP1A2HPGDGRIN2DGRIN3B
SCHEMBL8535601 0.82 HPGD (0.64) DAOCYP1A2GAAHPGDGRIN2D
SCHEMBL9387730 0.79 HPGD (0.60) DAOHPGDMEN1KMT2AALDH1A1
SCHEMBL9387632 0.79 DAO (0.65) DAOHPGDMEN1KMT2AALDH1A1
SCHEMBL9389777 0.79 DAO (0.65) DAOGAAHPGDMEN1KMT2A
SCHEMBL16767857 0.79 DAO (1.00) DAOGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2639080 0.77 DAO (0.61) DAOCYP1A2GAAHPGDGRIN2D
SCHEMBL9393070 0.76 DAO (0.63) DAOHPGDALDH1A1KDM4ENPC1
SCHEMBL9393317 0.76 FASN (0.57) DAOMEN1KMT2A
SCHEMBL9387807 0.76 RNASEH1 (0.47) DAOGAAHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0517876-B1 THERAPEUTIC BENZAZEPINE COMPOUNDS ZENECA LTD (GB) 1996-10-23 EP claimed
US-5446039-A Treating nervous system and brain disorder, acting as excitatory amino acid antagonist IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1995-08-29 US claimed
EP-0517876-A1 THERAPEUTIC BENZAZEPINE COMPOUNDS. ICI PLC (GB) 1992-12-16 EP claimed
WO-1992011854-A1 THERAPEUTIC BENZAZEPINE COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-23 WO claimed
EP-0517876-B1 THERAPEUTIC BENZAZEPINE COMPOUNDS ZENECA LTD (GB) 1996-10-23 EP disclosed
US-5541319-A REACTING SUBSTITUTED BENZAZEPINE ETHER WITH BORON TRIHALIDE TO FORM HYDROXY GROUP, FORMING SALT WITH BASE IF DESIRED ZENECA LIMITED (GB) 1996-07-30 US disclosed
US-5446039-A Treating nervous system and brain disorder, acting as excitatory amino acid antagonist IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1995-08-29 US disclosed
WO-1994007500-A1 2,5-DIHYDRO-2,5-DIOXO-1H-AZEPINES AND 2,5-DIHYDRO-2-OXO-1H-AZEPINES AND THE USE THEREOF AS EXCITATORY AMINO ACID AND GLYCINE RECEPTOR ANTAGONISTS WEBER ECKARD (US) 1994-04-14 WO disclosed
US-5254683-A Neurological disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-10-19 US disclosed
EP-0517876-A1 THERAPEUTIC BENZAZEPINE COMPOUNDS. ICI PLC (GB) 1992-12-16 EP disclosed
WO-1992011854-A1 THERAPEUTIC BENZAZEPINE COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-23 WO disclosed